NVIDIA and Medtronic are building an AI-enhanced endoscopy tool

NVIDIA is deepening its efforts to fight cancer using AI. The GPU maker is teaming with Medtronic to build AI into the GI Genius endoscopy tool (shown below). The two will use NVIDIA's IGX hardware and Holoscan medical platform to help detect the polyps that can lead to colorectal cancer. Doctors will get "AI-enhanced" diagnostic images, the companies say.

The first GI Genius systems built with NVIDIA tech are expected to arrive later this year. The device can use a range of AI tools, and Medtronic is betting that using NVIDIA's Clara platform could help develop algorithms for real-time medical procedures.

The news comes the same time as NVIDIA is expanding its BioNeMo Cloud service that helps bring generative AI to drug discovery. The new offering helps train AI models (and handle inference) used to develop new therapeutic proteins and otherwise advance fields like biology and chemistry. Researchers can speed up one of the most time-consuming processes in their pipeline, NVIDIA claims.

The news comes soon after Google unveiled AI technology for cancer therapy and ultrasound diagnosis. Other tech giants have devoted more of their AI work to healthcare in recent years. Intel partnered with Penn Medicine on AI to detect brain tumors, while Microsoft aimed to speed up cervical cancer detection and take some of the load from overworked doctors.

For NVIDIA, this is as much about translating its AI expertise to health tech as it is winning another customer. Still, the alliance could lead to some very practical benefits. As with some other AI-based cancer detection systems, this could help physicians begin treatment early and increase the chances of recovery.